Kezar Life Sciences, Inc. (KZR) Q4 2024 Annual Earnings
KZR·Reported March 25, 2025·Before market open
Diluted EPS came in at $-2.77, missed the $-2.71 consensus by $0.06.
Diluted EPS
$-2.77missed by $0.06
Consensus: $-2.71
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Kezar Life Sciences, Inc.'s Q4 2024 earnings report.
Kezar Life Sciences, Inc. (KZR) reported Q4 2024 earnings on March 25, 2025 before market open.
Kezar Life Sciences, Inc. reported diluted EPS of $-2.77 for Q4 2024.
EPS missed the consensus estimate of $-2.71 by $0.06.
You can read the 10-K periodic report (0001645666-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.